Protagonist Therapeutics (PTGX) Q3 2025 Earnings

6AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.58
0.27
1.13
1.98

Details

Expected EPS
-0.579289
Actual EPS
-0.55
Surprise EPS
0.03
Surprise Percent
+5.06%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.55 per share for Q3 2025.

0 Comments

Share your thoughts